Concepedia

John Panuto

JP

Statistics

Publications

3

Citations

425

H-Index

3

Active since

1999

Affiliations

Agence Universitaire de la Francophonie(Current)

John Panuto is an author at Agence Universitaire de la Francophonie specializing in pharmacy, pharmacotherapy, and antitumor interferon responses.

Publications per year

1999–2018

3

Publications

3

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Yajing Bao, Joy Beeler, Weerawat Manosuthi et al. · The Lancet Infectious Diseases · 2017 · 99 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Interferon-?? Production by T Lymphocytes from Renal Cell Carcinoma Patients: Evidence of Impaired Secretion in Response to Interleukin-12

James Ulchaker, John Panuto, Patricia Rayman et al. · Journal of Immunotherapy · 1999 · 15 citations

Life Sciences, Immunology, Oncology +17

1–3 of 3